Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2022-12-21 00:00:00 ET · period of report 2022-12-19 · accession 0001567619-22-021899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-21 | 2022-12-19 | AYTU | PYSZCZYMUKA GREG | Chief Commercial Off | P - Purchase | $0.24 | +100.0K | 182.1K | +122% | +$24.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-19 | P | A | 100,000 | $0.24 | 182,056 | D | — | — |